COVID-19: Resource Hub

During this unprecedented public health emergency, we are committed to signposting vital information and the latest guidance from health bodies, academic publications and other professional societies.

Please note, we will endeavour to keep this list updated with new resources as and when they become available. If you have a resource you’d like included on our hub, please use the form below.

BSAC is not responsible for ensuring the accuracy and/or updating the information published on external sites and/or in third party content.

Resources that are highlighted are the most recently posted resources

Filters
­­Pandora report: The Hidden Pandemic- COVID-19’s Impact on Antimicrobial Resistance
1mg: Coronavirus: No-Panic Helpguide (PDF)
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients
A call to action—stopping antimicrobial resistance
A Crucial Role for Antimicrobial Stewardship in the Midst of COVID-19
A meta-meta-analysis of co-infection, secondary infections, and antimicrobial resistance in COVID-19 patients
A MINI REVIEW ON NON-ANTIBIOTIC THERAPIES TO TARGET EMERGING ANTIMICROBIAL RESISTANCE DURING POST COVID ERA
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
A rapid review of the overuse of antibiotics during the COVID-19 pandemic: lessons learned and recommendations for the future
A real-time dashboard of clinical trials for COVID-19 (Global Coronavirus COVID-19 Clinical Trial Tracker)
A trade-off: antimicrobial resistance and COVID-19
Academy of Medical Royal Colleges – COVID-19 Resources
ADDRESSING EMPIRIC ANTIBIOTICS USAGE IN CORONAVIRUS DISEASE 2019 (COVID-19) PATIENTS
Africa CDC COVID-19 Resources
American Academy of Paediatrics – Critical Updates on COVID-19
American Academy of Paediatrics Journals – COVID-19: Overview and Evaluation – Pediatric Collection
American College of Physicians – COVID-19 Resources
American Society for Microbiology (ASM): COVID-19 research registry
AMR in COVID-19 times
An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic
An overview on the role of antibiotic therapy in the treatment of Coronavirus disease 2019 (COVID-19)
Anthrologica – COVID-19 SSHAP Briefs
ANTIBIOCLIC: COVID-19 : Algorithm for primary care
Antibiotic prescribing during the pandemic raises concern about drug resistance
Antibiotic prescribing in general practice during COVID-19
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
Antibiotic prescribing trends in primary care 2014–2022
Antibiotic resistance and the COVID‐19 pandemic: A dual crisis with complex challenges in LMICs
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis
Antibiotic resistance during and beyond COVID-19
Antibiotic Resistance during COVID-19: A Systematic Review
Antibiotic resistance patterns in infections associated with health care in a Third Level Center with hospital reconversion in the COVID-19 pandemic
Antibiotic resistance: how Covid-19 could be accelerating the ‘silent pandemic’
Antibiotic therapy applied to COVID-19: The antimicrobials overuse consequences in the current treatment
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Anticovid – a comprehensive open-access real-time platform of registered clinical studies for COVID-19
Anticovid – link to resource
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis
Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)
Antimicrobial Resistance and Antimicrobial Stewardship: Before, during and after the COVID-19 Pandemic
Antimicrobial resistance and COVID-19 syndemic: Impact on public health
Antimicrobial resistance and COVID-19: Intersections and implications
Antimicrobial resistance and the COVID -19 pandemic: A double threat
Antimicrobial Resistance as a Global Health Threat: The Need to Learn Lessons from the COVID-19 Pandemic
Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR
Antimicrobial resistance during COVID-19 pandemic: alternatives to combat bacterial infections
Antimicrobial Resistance Ignited by COVID-19 Pandemic: SOS for Antimicrobial Stewardship
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
Antimicrobial resistance in the age of COVID-19
Antimicrobial resistance in the emerging COVID-19 pandemic
Antimicrobial Resistance in the Global Health Network: Known Unknowns and Challenges for Efficient Responses in the 21st Century
Antimicrobial Resistance Is the Next Global Crisis, Triggered by Coronavirus Disease 2019
Antimicrobial Resistance Must Be Included in the Pandemic Instrument to Ensure Future Global Pandemic Readiness
Antimicrobial Resistance Pattern of Multidrug – Resistant Bacteria Isolated from COVID-19 Patients
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
Antimicrobial resistance through the looking-GLASS
Antimicrobial Resistance, Fueled by the COVID-19 Pandemic. Policy Brief November 2021
Antimicrobial resistance: The silent pandemic
Antimicrobial stewardship during the COVID-19 pandemic
Antimicrobial Stewardship During the Time of COVID-19
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times
Antimicrobial stewardship in Northern Ireland during COVID-19
Antimicrobial stewardship in the post COVID-19 pandemic era: an opportunity for renewed focus on controlling the threat of antimicrobial resistance
ANTIMICROBIAL STEWARDSHIP: A POWERFUL APPROACH
Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic
Antimicrobials Overuse in COVID-19: A Silent Pandemic of Antimicrobial Resistance
Antiviral drug discovery: preparing for the next pandemic
ASHP: Assessment of Evidence for COVID-19-Related Treatments
Association of American Medical Colleges (AAMC) – Coronavirus Clinical Guidance Repository
Association of Surgeons of GB & Ireland – COVID-19 Resources
Association of the British Pharmaceutical Industry (ABPI) – Responding to COVID-19
Automated diagnosis and quantitative analysis of COVID-19 on imaging
Avert (Information about HIV) – Coronavirus
​Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis
Bacterial Species and Antimicrobial Resistance of Clinical Isolates from Pediatric Patients in Yangon, Myanmar, 2020
BCCA: COVID-19 guidance for Vulnerable groups with congenital heart disease
Behavioural Insights Team Webinar: Applying behavioural insights to COVID-19 comms
Big Data Value Association (BDV) – COVID-19
Bio COVID-19 Therapeutic Development Tracker
BioMed Central – Coronavirus research highlights
BioMed Central – Methodologies for COVID-19 research and data analysis
BMJ Blog: Antibiotic resistance, chronic disease, and covid-19—a triple threat
BMJ Feature: How covid-19 is accelerating the threat of antimicrobial resistance
BMJ Learning – free access to COVID-19 relevant online courses
BMJ: Coronavirus (COVID-19) Hub
BPS Assessment: COVID-19: Prescribing Skills Free Learning Materials
BREATHE Health Data Research Hub for Respiratory Health (Usher Institute, University of Edinburgh)
British Assessment Bureau – COVID-19 awareness course
British Dental Association: Coronavirus Updates
British HIV Association – Coronavirus (COVID-19) and HIV – BHIVA Statements
British Infection Association – COVID-19 News
British Medical Association (BMA): Advice and support
British Oncological Association – Guidance on COVID-19
British Orthopaedic Association – Trauma and orthopaedic care in the UK during coronavirus pandemic
British Society for Immunology – Connect on Coronavirus
British Society of Gastroenterology COVID guidance and advice
British Thoracic Society COVID-19 guidance for the respiratory community
British Veterinary Association (BVA): Coronavirus
Cambridge University Press: Coronavirus Free Access Collection
CARB-X – COVID-19 May Worsen the Antibiotic-Resistance Crisis
Care England: Mouth care for patients with COVID-19 or suspected COVID-19
Care Quality Commission COVID-19 insight reports (Issue 3)
CDC:COVID-19 & Antibiotic Resistance
CEBM: Oxford COVID-19 Evidence Service
Cell Press – Coronavirus Research Hub
Centers for Disease Control and Prevention (CDC): Coronavirus (COVID-19)
Centre for Disease Dynamics Economics and Policy (CDDEP): ResistanceMap COVID-19 Global cases
Centre for Mathematical Modelling and Infectious Diseases (CMMID) – COVID-19 repository
China CDC COVID-19 Resources
CIDRAP: COVID-19 and Antimicrobial Stewardship Resources
CIDRAP: Novel Coronavirus (COVID-19) Resource Center
Clinical Characteristics and Disease Severity Among Infants With SARS-CoV-2 Infection in Montreal, Quebec, Canada
Clinical Microbiology and Infection (article Huttner et al.) – COVID-19: don’t neglect antimicrobial stewardship principles!
Clinical Practice Research Datalink (CPRD)
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: the blues of post-COVID-19 world
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: the blues of post-COVID-19 world
Cochrane Library: Coronavirus (COVID-19) Resources
Coinfections and antimicrobial resistance: Discovering positive and negative implications during COVID-19 pandemic
Combating antimicrobial resistance during the COVID-19 pandemic
Community engagement: The key to tackling Antimicrobial Resistance (AMR) across a One Health context?
Community Pharmacy Scotland: COVID-19 Hub
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
CONDOR – COVID-19 National DiagnOstic Research and Evaluation Platform
Considerations for AMR in the Covid-19 pandemic
Control of antibiotic resistance and superinfections as a strategy to manage COVID-19 deaths
Coronavirus Act 2020
Coronavirus Disease 2019 (COVID-19) Treatment & Management
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies
Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship (Brief Report by Coz Yataco & Simpson)
Coronavirus government response tracker
Coronavirus: What Mesothelioma Cancer Patients Should Know
Council of Europe – Artificial intelligence and the control of COVID-19
COVID and AMR: Crisis Reframes Antibiotics Fight
COVID Evidence Database
COVID-19 & Antimicrobial Resistance
COVID-19 and antimicrobial resistance: A cross-study
COVID-19 and Antimicrobial Resistance: A Review
COVID-19 and Antimicrobial Resistance: the case for a One Health approach
COVID-19 and Antimicrobial Stewardship: Lessons Learned, Best Practices and Future Implications
COVID-19 and the fight against antimicrobial resistance
COVID-19 association with multidrug-resistant bacteria superinfections: Lessons for future challenges
COVID-19 Chinese Consultation Center Release
COVID-19 disruptions may have fueled hospital superbug outbreak
COVID-19 drug practices risk antimicrobial resistance evolution
COVID-19 Forecast Hub (USA based)
COVID-19 Genomics UK Consortium
COVID-19 Infection Study (Nuffield Department of Medicine)
COVID-19 Longitudinal Research Hub (CLOSER)
COVID-19 Mass Spectrometry Coalition
COVID-19 Mixed Impact on Hospital Antimicrobial Stewardship Activities: A Qualitative Study in UK-Based Hospitals
COVID-19 Oxford Vaccine Trial
COVID-19 pandemic and antimicrobial resistance in developing countries
Covid-19 Pandemic and Antimicrobial Resistance: A Scoping Review
COVID-19 pandemic: A trigger for the rise in antimicrobial resistance
COVID-19 pandemic: challenges, facts and risks of antibiotic resistance
COVID-19 Pandemic: Upswing in Antibiotic Misuse
COVID-19 Protein Portal
COVID-19 Research Project Tracker by UKCDR & GloPID-R
COVID-19 Studies from the World Health Organization Database
COVID-19 tele-education series for healthcare providers in low and middle income countries
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance
COVID-19 vaccine development pipeline (LSHTM)
COVID-19, superinfections and antimicrobial development: What can we expect?
Covid-19: Antimicrobial misuse in Americas sees drug resistant infections surge, says WHO
COVID-19: Impact on prescribing and antimicrobial resistance
Cropping up Crisis at the Nexus between COVID-19 and AMR in Africa: A Scoping Review and Synthesis of Early Evidence
DECOVID
Department of Health (Ireland) – COVID-19 Resources
Department of Health (Northern Ireland) COVID-19 Updates
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
Drug-Resistant Bacteria Outbreak Linked to COVID-19 Patient Surge
E-learning for Healthcare – Coronavirus
EB Medicine – COVID-19 resources
EBSCO: Information and Resources to Help During the COVID-19 Pandemic
ECDC: COVID-19 pandemic: increased transmission in the EU/EEA and the UK (seventh update)
ECDC: National information resources for the public on COVID-19
Electronic Distribution of COVID-19 Guidelines: A Potential Tool for Antimicrobial Stewardship Programs
Elixir – support Covid-19 research
ELSEVIER: Novel Coronavirus Information Center
EMBL-EMI COVID-19 Data Portal
EMCRIT: Internet Book of Critical Care (IBCC)
Emerald Open Research Coronavirus Collection
Emerging Infectious Diseases Journal – COVID-19 expedited articles
EPPI Centre – COVID-19: a living systematic map of the evidence
ESCMID eAcademy: COVID-19 Learning Resources
ESCMID Emerging Infections Task Force (EITaF): Outbreak news
EU Clinical Trials Register – Clinical trials for COVID-19
EU Open Data Portal Coronavirus data
European Academy of Allergy and Clinical Immunology (EAACI) COVID-19 Resource Centre
European Clinical Research Infrastructure Network (ECRIN) – COVID-19 Taskforce
European Council EU actions to tackle COVID-19 disinformation
European Hematology Association: COVID-19 Information Center
European Institute of Innovation and Technology (EIT) – COVID-19 Response
European Medicines Agency – Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
European Medicines Agency (EMA) First COVID-19 treatment recommended for EU authorisation (Remdesivir)
European Medicines Agency (EMA): COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes
European Medicines Agency (EMA): EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19
European Medicines Agency: Coronavirus
European Medicines Agency: COVID-19 vaccines: development, evaluation, approval and monitoring
European Medicines Agency: COVID-19 vaccines: key facts
European Pharmaceutical Review – COVID-19 Hub
European Respiratory Society COVID-19 Resource Centre
European Society for Blood and Marrow Transplantation – COVID-19 webinars
European Society of Cardiology COVID-19 and Cardiology
European Vaccination Information Portal: COVID-19
Eurosurveillance: Coronavirus Disease
Evaluation of Bacterial Coinfection and Antibiotic Resistance in Patients with COVID-19 Under Mechanical Ventilation
Evidence Aid: Covid-19 Information Portal
Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic
Expert Review: It is complicated. Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review
Facing the Pandemic of Antimicrobial Resistance
Faculty of Clinical Informatics: COVID-19 Resources and Guidance
FDA: Coronavirus Disease 2019 (COVID-19)
Financial Times: Coverage of the coronavirus
FIND (Foundation of Innovative New Diagnostics) SARS-COV-2 Diagnostic Pipeline
FIND COVID-19 Diagnostics Resource Centre
Finnish Institute for Health and Welfare – COVID-19 latest updates
Fogarty International Centre: Coronavirus resources
Freethink: List of potential coronavirus treatments and vaccines
Freethink: The Coronavirus Fatality Rate: Explained
Frontiers – Coronavirus Knowledge Hub
FutureLearn: Airway Matters
FutureLearn: COVID-19 Critical Care: Understanding and Application
FutureLearn: COVID-19 Diagnostics and Testing
FutureLearn: COVID-19 in Africa – Managing the Outbreak in Primary Care Settings
FutureLearn: COVID-19 Psychological First Aid
FutureLearn: COVID-19: Effective Nursing in Times of Crisis
FutureLearn: COVID-19: Pandemics, Modelling, and Policy
FutureLearn: COVID-19: Tackling the Novel Coronavirus
FutureLearn: Global Health Perspectives
FutureLearn: Managing COVID-19 in General Practice
FutureLearn: Social Care During COVID-19: Coping with Self-Isolation and Social Distancing
FutureLearn: The Role of Vaccines in Preventing Infectious Diseases
FutureLearn: Vaccine Development: Finding a Vaccine for COVID-19 and Future Pandemics
GAVI The Vaccine Alliance – Responding to COVID-19
Gavi: Is antimicrobial resistance exacerbating the COVID-19 pandemic?
General Dental Council – COVID-19 Information, standards and guidance
Genetic mechanisms of critical illness in Covid-19
Geneva Centre for education and research in humanitarian action COVID-19 Scientific Resource Centre
Genomics England GenOMICC study on COVID-19 patients
GISAID Initiative – Data sharing from all influenza viruses and the coronavirus causing COVID-19
GLOBAL ACCESS TO ANTIMICROBIALS AND ENHANCED EMERGENCE OF AMR IN COVID-19 ERA
Global Alliance for Genomics and Health – GA4GH Community Response to COVID-19
Global antimicrobial stewardship and the need for pharmaceutical system strengthening for antimicrobials within a One Health approach
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)
Global Coronavirus COVID-19 Clinical Trial Tracker (Cytel)
Global Genes (Allies in Rare Disease) – COVID-19 Resources
Global Research Collaboration for Infectious Disease Preparedness – COVID-19
Global research publications on irrational use of antimicrobials: call for more research to contain antimicrobial resistance
Global Resilience and New Strategies Needed for Antimicrobial Stewardship during the COVID-19 Pandemic and Beyond
Global Virus Network – SARS-CoV-2 Response Effort Highlights
GOV.UK COVID-19 Press Conference Slides with Annex (2020-06-05)
Grey Matter Learning: Free Coronavirus (Covid-19) Online Training Course
Hand Hygiene and Antimicrobial Resistance in the COVID-19 Era: An Observational Study
Harvard Medical School: Coronavirus Resource Center
Harvard University – COVID-19 Webinars for Healthcare Providers
Health & Safety Executive – Coronavirus
Health Data Research UK
Health Data Research UK Innovation Gateway COVID-19 Gateway Resources
Health Data Research UK International COVID-19 Data Research Alliance and Workbench
Health Education England – Coronavirus resources
Health Protection (Coronavirus) Regulations 2020
Health Protection Scotland
Healthcare Infection Society – COVID-19 research and commentary
Healthcare Infection Society: COVID-19 resources
How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
How COVID-19 has influenced antimicrobial resistance
How COVID-19 Has Influenced Public Interest in Antimicrobials, Antimicrobial Resistance and Related Preventive Measures
How did COVID-19 impact on dental antibiotic prescribing across England?
HSC Public Health Agency (Northern Ireland)
IBMS: COVID-19 resources
ICU One Pagers: Critical care education
IDSA Guidelines on the Diagnosis of COVID-19
IDSA: COVID-19: Resource Centre
IDstewardship: COVID-19 Resources For Pharmacists
IFMSA Policy Document Antimicrobial Resistance
Impact of Antibiotic Consumption on Antimicrobial Resistance to Invasive Hospital Pathogens
Impact of COVID-19 pandemic on anti-microbial resistance and secondary microbial infections
Impact of COVID-19 Pandemic on Antimicrobial Resistance Pattern; Transition from Resistivity to Susceptibility
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review
Impact of SARS-CoV-2 on Antibiotic Resistance: Evolution of Treatment and Control Strategies
Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals
Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
Impact of the COVID Pandemic in Susceptibility Patterns of Gram-Positive Organisms: A Report from the SENTRY Antimicrobial Surveillance Program
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey
Imperial College Health Partners COVID-19 data prioritisation group
Imperial College: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
Increased antimicrobial resistance during the COVID-19 pandemic
Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance [Systematic review]
Infectious Disease Advisor COVID-19 resources
Infectious Disease Hub – COVID-19 Hub
Information Commissioner’s Office – Data protection and coronavirus: what you need to know
Institut Pasteur – COVID-19 Disease Updates
Institute of Health Metrics and Evaluation (University of Washington) – COVID-19 resources
Intensive Care National Audit and Research Centre – COVID-19 activities
International Atomic Energy Association COVID-19 Webinars
International Journal of Antimicrobial Agents (ISAC) SARS CoV-2 / COVID-19 Therapeutic and Prevention
International Monetary Fund Policy Tracker – COVID-19
International Network for Government Science Advice – COVID-19
International Pharmaceutical Federation (FIP) COVID-19 Information Hub
International Science Council – COVID-19 Global Science Portal
International Society for Infectious Diseases – COVID-19
Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01
Is the COVID19 Pandemic Accelerating the Existing Public Health Problem of Antimicrobial Resistance?
JAC-AMR (Opinion – Debate) – The COVID-19 pandemic will not result in increased antimicrobial resistance prevalence
JAC-AMR (Opinion – Debate): The COVID-19 pandemic will result in increased antimicrobial resistance rates
JAC-AMR: The impact of the COVID-19 pandemic on antimicrobial resistance (a debate)
JAC: a comprehensive open-access real-time platform of registered clinical studies for COVID-19
JAC: An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London (Original research)
JAC: Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey (Original research by Beović et al).
JAC: Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic (Research letter by Martin et al.)
JAC: Bringing evidence from press release to the clinic in the era of COVID-19 (Viewpoint)
JAC: COVID-19 and the potential long-term impact on antimicrobial resistance
JAC: COVID-19, antibiotics and One Health: a UK environmental risk assessment (Research letter by Hodge et al.)
JAC: COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
JAC: Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
JAC: Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis (Kashour et al.)
JAC: Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
JAC: Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers (Research letter)
JAC: Implications of antibiotics use during the COVID-19 pandemic: present and future (Viewpoint. Miranda et al.)
JAC: Influences on antibiotic prescribing by non-medical prescribers for respiratory tract infections: a systematic review using the theoretical domains framework.
JAC: Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers (Original Research)
JAC: Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control (Original research)
JAC: Lopinavir pharmacokinetics in COVID-19 patients
JAC: Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients
JAC: Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis (Research letter)
JAC: Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
JAC: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial
JAC: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial (Comment on)
JAC: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial (Letter to the Editor – Lê et al. authors’ response)
JAC: Remdesivir and GS-441524 plasma concentrations in patients with end-stage renal disease on haemodialysis (Research Letter)
JAC: Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection (Original research)
JAC: Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial (Original research)
JAC: Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
JAC: Systematic review. Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis (by Simmons et al.)
JAC: The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics
JAC: Treating COVID-19: are we missing out the window of opportunity? (Viewpoint by Sundararaj Stanleyraj et al.)
JAMA Network: COVID-19 collection
Johns Hopkins University & Medicine: Coronavirus Resource Centre
Joint Programming Initiative on AMR (JPIAMR): Consideration for antibiotic resistance in the COVID-19 pandemic
Journal of Clinical Virology – Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Learning from COVID-19 to Tackle Antibiotic Resistance
Les misérables: a Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developed Countries
Leveraging antimicrobial stewardship programs in response to the coronavirus disease 2019 (COVID-19) public health emergency
Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019
LitCovid
London School of Hygiene and Tropical Medicine – COVID-19 and Antimicrobial Resistance
London School of Hygiene and Tropical Medicine (LSHTM): COVID-19 latest research
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
MAG Online Library: Coronavirus/COVID-19 Hub
Management Services for Health – COVID-19 Responding to the pandemic
Mapping COVID-19 research in context (Pro-Sharp) Research and Innovation Centre
Max Planck Society COVID-19-related research
Mayo Clinic (US) – COVID-19
MDPI COVID-19 Academic Resources Center
Medical Protection – COVID-19 webinars
Medicines and Healthcare products Regulatory Agency (MHRA) Guidance
Medicines Discovery Catapult (MDC): COVID information and opportunities for the drug discovery community
Medscape UK – COVID-19 resources
Microbiology Society – COVID-19 blog
Microbiology Society – In pictures: the first images of a coronavirus (1964)
MIDAS (University of Pittsburgh) Online Portal for COVID-19 modeling research
Milken Institute – COVID-19 treatment and vaccine tracker
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective
Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage
NASA response to coronavirus
National Pharmaceutical Association – Coronavirus updates
Nature Index – COVID-19
Nature Reviews Immunology – Complement as a target in COVID-19?
Natures News: The lightning-fast quest for COVID vaccines — and what it means for other diseases
NCBI SARS-CoV-2 Resources
Neonatal and Paediatric Pharmacy Group – COVID-19
NESTA Report: Artificial Intelligence and the fight against COVID-19
NHS Blood and and Transplant (NHSBT) COVID-19 Plasma Programme
NHS Confederation – COVID-19: Supporting members
NHS Digital – Response to Coronavirus
NHS e-Library for health online coronavirus resources for training staff
NHS Education for Scotland Coronavirus – Resources for people working in health and care
NHS England: Coronavirus guidance for clinicians and NHS managers
NHS Health Research Authority (HRA): COVID Guidance
NHS Health Research Authority (HRA): list of approved COVID research
NHS Health Research Authority COVID-19 – guidance for using patient data
NHS Specialist Pharmacy Service – Coronavirus resources
NHS: Coronavirus guidance for clinicians and NHS Managers
NICE Guideline: COVID-19 rapid guideline -antibiotics for pneumonia in adults in hospital
NICE: Covid-19 Resources
NIH COVID-19 Treatment Guidelines – What’s New
NIH Open-access data and computational resources to address COVID-19
NIH: Coronavirus (COVID-19)
NIHR Be Part of Research – COVID-19 Studies
Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?
Nursing Standard: COVID-19 Resources
Nursing Times – COVID-19 guideline hub
Office for National Statistics – COVID-19 data and analysis (UK)
Online COVID-19 vaccine development congress organised by the International Society for Vaccines
Open Data Watch – Data in the time of COVID-19
Organisation for Economic Cooperation and Development (OECD) Tackling Coronavirus – Contributing to a global effort
Outpatient Antimicrobial Stewardship Utilizing a Decentralized Model
ow COVID-19 Has Influenced Public Interest in Antimicrobials, Antimicrobial Resistance and Related Preventive Measures
Oxford University Press: COVID-19 related content form online resources and leading journals
PAGER-CoV: a web-based database of coronavirus-related functional genomic study results
Pan American Health Organisation (PAHO) Infographic: Antimicrobial Resistance and COVID-19
Pandemic hits: Evaluation of an antimicrobial stewardship program website for hospital communication during the coronavirus disease 2019 (COVID-19) pandemic
Parliamentary Office of Science and Technology: COVID-19 Updates
Patients Association – Testing and tracing systems in the UK
Paul Ehrlich Institut Newsroom – Coronavirus Research
Paving the Way to Overcome Antifungal Drug Resistance: Current Practices and Novel Developments for Rapid and Reliable Antifungal Susceptibility Testing
PeerJ Collection: Coronaviruses and Viral Respiratory Infections
Perception, Attitude, and Confidence of Physicians About Antimicrobial Resistance and Antimicrobial Prescribing Among COVID-19 Patients: A Cross-Sectional Study
Perception, Attitude, and Confidence of Physicians About Antimicrobial Resistance and Antimicrobial Prescribing Among COVID-19 Patients: A Cross-Sectional Study From Punjab, Pakistan
PEW Trust: Superbugs in the News: How COVID-19 Is Increasing Antibiotic Use
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review
PHG Foundation (University of Cambridge) The relevance of coronavirus mutation (blog)
PHG Foundation (University of Cambridge) Using whole genome sequencing to help combat COVID-19 (blog)
PLOS ONE – COVID-19 pandemic collection
Podcast: Society for Infectious Disease Pharmacists (SIDP): What is Happening Right Now? COVID-19 Challenges and Silver Linings
Post-Covid-19 Era: What is Next?
Potential ways to address antimicrobial resistance across India and wider exacerbated by COVID-19
Prediction of tsunami of resistance to some antibiotics is not far-fetched which used during COVID-19 pandemic
PREPRINT: The Use of Procalcitonin as an Antimicrobial Stewardship Tool and a Predictor of Disease Severity in COVID-19
Presymptomatic, asymptomatic and post‑symptomatic transmission of SARS‑CoV‑2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance
Procalcitonin levels and antibiotic use associations with COVID-19 disease severity in hospitalized adults and the potential for an increase in antibiotic resistance: a cross-sectional clinical and public health analysis
Proceedings of the National Academy of Sciences of the United States of America (PNAS) – COVID-19 News and Resources
Profile of Bacterial Infections in COVID-19 Patients: Antimicrobial Resistance in the Time of SARS-CoV-2
PROPOFOLOGY: COVID ICU PROTOCOLS
Public Health England
Public Health England – Finding the evidence: Coronavirus
Public Health England – Wider Impacts of COVID-19 on Health monitoring tool
Public Health England Report – Disparities in the risk and outcomes of COVID-19
Public Health Scotland – COVID-19 Surveillance Data
Public Health Wales
Public Health Wales – COVID-19 Surveillance Data
Public Media Alliance: Coronavirus: Resources and best practices
Quality Improvement Scotland (NHS) – Coronavirus
Rapid Reviews COVID-19 (MIT Press)
RCPCH: COVID-19 – resources for parents and carers
REACT: COVID-19 and AMR
REACT: COVID-19 and AMR – what do we know so far?
RECOVERY Trial (University of Oxford)
Regulatory Affairs Professionals Society (RAPS) – COVID-19 vaccine tracker
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Research Data Alliance Recommendations and guidelines on data sharing for COVID-19
Resourcing for health in the COVID-19 era: Maximising bang for buck
Respiratory co-and superinfections in COVID-19
Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
Review: COVID-19 and Antimicrobial Resistance
Review: Empiric Antibiotics in COVID 19, A Narrative Review
Review: Impact of COVID-19 on Antimicrobial Resistance in Paediatric Population (a Narrative Review)
Review: Impact of COVID-19 on antimicrobial resistance: revealing the hidden threats
Review: Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Review: The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic
ReviewA parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic
REVIVE: COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever
Rising antimicrobial resistance: an evolving epidemic in a pandemic
Robert Koch Institute – COVID-19 in Germany
Royal College of Anaesthetists – COVID-19 Resources
Royal College of General Practitioners – COVID-19 Resources
Royal College of Nursing: COVID-19
Royal College of Obstetrics & Gynaecologists – Coronavirus (COVID-19), pregnancy and women’s health
Royal College of Ophthalmologists – COVID-19 Resources
Royal College of Pathologists – Coronavirus resource hub
Royal College of Physicians & Surgeons of Glasgow – COVID-19 Resources
Royal College of Physicians of London – COVID-19 Resources
Royal College of Radiologists – COVID-19
Royal College of Surgeons (Edinburgh) – COVID-19 Resources
Royal College of Surgeons: COVID-19 Resources
Royal National Orthopaedic Hospital NHS Trust – COVID-19 training for the independent sector
Royal Pharmaceutical Society – COVID-19 resources
Royal Society for the Promotion of Health – COVID-19 Resources
Royal Society of Biology and COVID-19
SAGE Journals Resource Centre
ScienceMag – Coronavirus: Research, Commentary, and News
Scientific Africa Call for Papers: Special Issue on “Covid-19 in African countries: multi-disciplinary perspectives on the global pandemic in Africa” Deadline 30th September 2020 (For publication February 2021)
Scilit – access the latest research on COVID-19
Secondary infections, antibiotic chemotherapy and antibiotic resistance in the context of COVID-19
Sepsis Alliance: COVID-19 Resources
Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance?
Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
Siemens: About Coronavirus (PDF)
Silent slow pandemic of antimicrobial resistance
Skills for Health: Coronavirus (COVID-19) Awareness​ course
Social Care Institute for Excellence – Coronavirus advice for social care
Social Science in Humanitarian Action Platform (SHHAP) – COVID-19 updates
Society for Healthcare Epidemiology of America (SHEA): NOVEL CORONAVIRUS (COVID-19)
Society of Critical Care Medicine – COVID-19 Journal articles
Society of Infectious Diseases Pharmacists COVID-19 resources
Specialist Pharmacy Service – COVID-19
Springer Nature: SARS-CoV-2 and COVID-19
SSRN (Social Science Research Network) Coronavirus and Infectious Disease Research page
Stanford University – COVID-19 Updates
Start Smart, Then Focus: Antimicrobial Stewardship Practice at One NHS Foundation Trust in England Before and During the COVID-19 Pandemic
Stop misinformation about antibiotics for covid -19, or resistance will rise
Superinfections in COVID-19 Patients: Role of Antimicrobials
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Swiss Medical Weekly: COVID-19 published articles
Taylor and Francis Online: Coronavirus Research Archive
The Academy of Medical Sciences – COVID-19 preclinical drug development database
The Academy of Medical Sciences COVID-19 Information Hub
The Academy of Medical Sciences Report – Preparing for a challenging winter 2020/21
The African Academy of Sciences – Global Health Security: COVID-19 in Africa
The aftermath of corona virus disease on antimicrobial resistance across low- and middle-income countries
The AGILE Clinical Trial Platform
The British Society for Allergy & Clinical Immunology – COVID-19 Resources
The COVID-19 Pandemic Enhanced the Decade-Long Trend of the Decreasing Utilization of Antibiotics
The COVID-19 pandemic: a threat to antimicrobial resistance containment
The Economist: Coverage of the coronavirus
The Economist: Tracking the Pandemic
The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study
The Francis Crick Institute COVID-19 Consortium
The Global Health Network: Coronavirus
The Health Foundation – Responding to COVID-19
The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review
The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units
The impact of the COVID-19 pandemic on antimicrobial resistance: a debate
The Infectious Diseases Data Observatory (IDDO) – COVID-19
The Interacademy Partnership Academy Response to COVID-19
The invisible pandemic: Antimicrobial resistance
The Lancet: Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
The Lancet: COVID-19 Resource Centre
The Lancet: Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
The National Academies Coronavirus Resource Collection
The National Academies COVID-19 Responses and Resources
The New England Journal of Medicine: COVID-19
The NHS COVID-19 app support website – NHS.UK
The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance
The Oxford Vaccine
The Pan African Medical Journal Special issue on COVID-19 in Africa
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
The Proliferation of Antimicrobial Resistance Due to COVID-19 Sterilization Practices
The rise in antimicrobial resistance: An obscure issue in COVID-19 treatment
The Royal College of Emergency Medicine – COVID-19 Resources
The Royal College of Veterinary Surgeons: Coronavirus (COVID-19)
The Royal Society of Medicine: COVID-19 Learning Hub
The SARS-CoV-2 RNA–protein interactome in infected human cells
The silent pandemic Addressing antimicrobial resistance
The Social Science Research Council: COVID-19 and the the social sciences
The Society for Healthcare Epidemiology of America: Novel coronavirus 2019 resources
The state of current research on COVID-19 and antibiotic use: global implications for antimicrobial resistance
The UK Clinical Virology Network – Journal Watch
The Unnecessary Uses of Antibiotics During COVID-19 Fulfill Antibiotic Resistance
Therapeutic Approaches for SARS-CoV-2 Infection
TranspariMED – All COVID-19 clinical trials at a glance
UK Biobank COVID-19 updates
UK Collaborative on Development Research (UKCDR) – COVID-19
UK Data Service: COVID-19 themed resources
UK Government – Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19)
UK Intensive Care Society coronavirus resources
UK Lighthouse Labs Network
UKRI: Coronavirus – the science explained
Understanding the role of bacterial and fungal infection in COVID-19
UNESCO COVID-19 Response
United Nations Department of Economics and Social Affairs
University of Oxford – COVID-19 Trials Tracker
Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario
Use of antimicrobials in patients with COVID-19 without prior evaluation of an associated bacterial infection
Usher Institute COVID-19 Webinars
VHL Regional Portal: Coronavirus Disease
Virtual College – Preventing COVID-19
War on superbugs must follow defeat of Covid-19
WASH FIT Training Package (Revised 2020) – Implementing WASH in HCF in the context of COVID-19
Weakening the waves: Impact of a syndrome-based antimicrobial stewardship intervention during COVID-19
Webinar – Antimicrobial Stewardship in the Context of COVID-19 (Dr Diane Ashiru-Oredope)
Welsh Government – Coronavirus
WHO clinical management guidance for suspected COVID-19
WHO: Antimicrobial Stewardship – A competency-based approach
WHO: Clinical Care Severe Acute Respiratory Infection
WHO: COVID-19 Social Science Working Group
WHO: COVID-19: How to put on and remove personal protective equipment (PPE)
WHO: COVID-19: Operational Planning Guidelines and COVID-19 Partners Platform to support country preparedness and response
WHO: Draft landscape and tracker of COVID-19 candidate vaccines
WHO: Emerging respiratory viruses, including COVID-19: methods for detection, prevention, response and control
WHO: ePROTECT Respiratory Infections (EN)
WHO: Infection Prevention and Control (IPC) core components and multimodal strategies
WHO: Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)
WHO: Infographic – AMR and COVID-19
WHO: Introduction to Go.Data – Field data collection, chains of transmission and contact follow-up
WHO: Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework
WHO: Pandemic preparedness
WHO: Policy guidance on integrated antimicrobial stewardship activities
WHO: Preventing the COVID-19 pandemic from causing an antibiotic resistance catastrophe
WHO: Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19)
WHO: Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO: Severe Acute Respiratory Infection (SARI) Treatment Facility Design
WHO: Standard precautions: Hand hygiene
WHO: Stop the COVID-19 pandemic from becoming an AMR catastrophe
WHO: Tackling antimicrobial resistance in the COVID-19 pandemic
Wiley Online Library: Covid-19: Novel Coronavirus Outbreak
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance (Editorial)
Working to Fight AMR – COVID-19 Media Centre
World Economic Forum – Hospital-at-Home during COVID-19
World Economic Forum: Handwashing is not just for coronavirus
Worldometer – COVID-19 data
Worrying increase in antimicrobial resistance associated with COVID-19


    Upload a document

    Who We Are

    Get in Touch

    Information

    © 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
    53 Regent Place, Birmingham B1 3NJ
    Registered Charity
    Top